Skip to main content

Electronic Skin Patches Ensure Early Diagnosis through Remote Monitoring

 

An electronic skin patch is a wearable device which adheres to the skin. It is a stick-on patch which can be worn on the body and is capable of collecting, monitoring and transmitting various health metrics such as respiration, temperature, blood glucose, blood pressure, and heartbeat to a smartphone, wirelessly. At present there are three major types of skin patches available in the market, including transdermal patches (drug delivery through skin), remote monitoring (patient vitals and blood glucose), and bioelectric stimulation (chronic pain management).

The electronic component of the electronic skin patch includes the electronic functionality including actuators, processors, sensors, and communication, permitting the device to be linked with other devices.

The electronic skin patch is ultra-thin and flexible, and designed for next-generation information for communication with the help of microelectronics and sensors by revealing  data about body temperature, UV radiation absorption, and blood oxygen levels. It is also used for drug delivery and therapeutic interventions. It can help in reducing the healthcare cost by decreasing hospital re-admission, reducing medication non-adherence, and increasing wellness management with connected smart devices and wearables to gather and evaluate medical data.

According to the market intelligence published by BIS Research, titled “Global Electronic Skin Patches Market - Analysis and Forecast, 2019-2024”, the electronic skin patches market generated a revenue of $3,899.1 million and is projected to grow at a CAGR of 17.22% during the forecast period from 2019 to 2024.

The growth of the market is driven by factors including the growing geriatric population that leads to a surge in exigency of electronic skin patches, increasing burden of chronic and lifestyle-associated diseases elevating the requirement of continuous monitoring and treatment of diseases, increasing inclination of people toward personal health and fitness, and growing prominence for point-of-care technologies, among others.

Electronic skin patches offer several benefits, including chronic disease management through initial intervention, promotion of a healthy lifestyle, early diagnosis through remote monitoring, enhanced transparency and patient independence, remote monitoring and self-managed care, and is an inexpensive and disposable technology.

The global electronic skin patches market entails several large-scale as well as small-scale manufacturers. Currently, the manufacturers in the market have ample opportunities to expand their services and to earn significant revenues. Some of the strategies followed by the manufacturers are product approvals, launches, joint ventures, agreements, collaborations, partnerships, mergers and acquisitions, and business expansions.

Some of these major players operating in the market include Abbott Laboratories, BioTelemetry, Inc., DexCom, Inc., General Electric Company, Insulet Corporation, iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals, Medtronic, Plc., MC10, Inc., Omron Corporation, VivaLNK, and VitalConnect.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale. Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices. BIS Research recently published a market intelligence report titled “ Global Neurostim...